< Back to previous page
Researcher
Robert Snoeck
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 10 of 15
- Viral Oncology: molecular biology and pathogenesis of post-transplant lymphoproliferative disorder (PTLD)From13 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Dynamics of cytomegalovirus infection: evolution towards antiviral drug resistanceFrom1 Feb 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Intravital microscopy platform for infectious and inflammatory diseasesFrom1 May 2020 → TodayFunding: FWO Medium Size Research Infrastructure
- Challenges and opportunities in the management of herpes simplex virus antiviral resistanceFrom17 Apr 2018 → 17 Apr 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Unravelling the role of BK polyomavirus genetic variants in viral pathogenicity and clearance in kidney transplant recipientsFrom1 Apr 2018 → 8 Mar 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
- Challenges and opportunities in the management of herpesvirus antiviral-resistanceFrom1 Jan 2018 → 31 Dec 2021Funding: FWO research project (including WEAVE projects)
- Unraveling the role of BK polyomavirus variants and of cellular CMP kinase on viral pathogenicity and clearance in renal-transplant patientsFrom1 Oct 2017 → 30 Sep 2021Funding: FWO Applied Biomedical Research (TBM)
- Automated real-time quantitative live cell analysisFrom1 Oct 2016 → 30 Sep 2018Funding: Fund Recuperation Fiscal Exemption
- The role of Tumor Micro-Environment in the pathogenesis and prognosis of EBV lymphomas: a study in human tumor biopsies and an novel Patient Derived Tumor Xenograft mouse modelFrom1 Sep 2016 → 25 Nov 2020Funding: Private funding of national origin - undefined
- MERKEL CELL CARCINOMA, TOWARDS THE IDENTIFICATION OF NOVEL MOLECULAR TARGETS AND THE ESTABLISHMENT OF A THREE-DIMENSIONAL CELL CULTURE MODELFrom9 Nov 2015 → 14 Dec 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
181 - 190 of 236
- New prodrugs of adefovir and cidofovir(2011)
Authors: Graciela Andrei, Jan Balzarini, Robert Snoeck
Pages: 3527 - 3539 - Identification of bicyclic sulfone inhibitors of HHV-6 targeting the HHV-6 U77 helicase(2011)
Authors: Lieve Naesens, Graciela Andrei, Robert Snoeck, D Gerry, JE Banning, PD Wilkerson, ZM Renew, CE Stephens
Pages: A60 - A61 - Activities of different classes of acyclic nucleoside phosphonates against BK virus in primary Human renal cells(2011)
Authors: Dimitrios Topalis, Graciela Andrei, Robert Snoeck
Pages: 1961 - 1967 - Dipeptidyl peptidase IV dependent water-soluble prodrugs of highly Llpophilic bicyclic nucleoside analogues(2011)
Authors: Jan Balzarini, Graciela Andrei, Robert Snoeck
Pages: 1927 - 1942 - Synthesis of new C5-(1-substituted-1,2,3-triazol-4 or 5-yl)-2'-deoxyuridines and their antiviral evaluation(2011)
Authors: Jan Balzarini, Robert Snoeck, Graciela Andrei
Pages: 778 - 786 - Synthesis and SAR studies on azetidine-containing dipeptides as HCMV inhibitors(2011)
Authors: Robert Snoeck, Graciela Andrei, Jan Balzarini
Pages: 1155 - 1161 - Anti-HCMV Compounds(2011)
Authors: Graciela Andrei, Robert Snoeck
Pages: 227 - 282Number of pages: 56 - Study of camelpox virus pathogenesis in athymic nude mice(2011)
Authors: Sophie Duraffour, Patrick Matthys, Joost van den Oord, Tim De Schutter, Robert Snoeck, Graciela Andrei
- Novel antiviral C5-substituted pyrimidine acyclic nucleoside phosphonates selected as human thymidylate kinase substrates(2011)
Authors: Dimitrios Topalis, Robert Snoeck, Graciela Andrei, Jan Balzarini
Pages: 222 - 232 - Design, synthesis and preliminary antiviral screening of new N-phenylpyrazole and dihydroisoxazole derivatives(2010)
Authors: Christophe Pannecouque, Graciela Andrei, Robert Snoeck, Jan Balzarini
Pages: 1025 - 1035
Patents
1 - 6 of 6
- Prodrugs of nucleoside phosphonates (Inventor)
- Novel prodrugs of nucleoside phosphonates (Inventor)
- Novel purine derivatives and drugs comprising same (Inventor)
- Prodrugs of fluorinated acyclic nucleoside phosphonates (Inventor)
- Prodrugs of fluorinated acyclic nucleoside phosphonates (Inventor)
- Novel prodrugs of nucleoside phosphonates (Inventor)